Evidence map›Paper›PMID 26147851›Full record

ArticlePloS one2015

Identities of P2 and P3 Residues of H-2Kb-Bound Peptides Determine Mouse Ly49C Recognition.

Elsa A Marquez, Kevin P Kane

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Recognition ofInnate immunity · 2023
    Review
  4. Critical role for the Ly49 family of class I MHC receptors in adaptive natural killer cell responses.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Elsa A MarquezMedical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Kevin P KaneMedical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
University of Alberta · CA

Funding

Canadian Institutes of Health Research 43864
6 · The paper itself

Abstract

Ly49 receptors can be peptide selective in their recognition of MHC-I-peptide complexes, affording them a level of discrimination beyond detecting the presence or absence of specific MHC-I allele products. Despite this ability, little is understood regarding the properties that enable some peptides, when bound to MHC-I molecules, to support Ly49 recognition, but not others. Using RMA-S target cells expressing MHC-I molecules loaded with individual peptides and effector cells expressing the ectodomain of the inhibitory Ly49C receptor, we found that two adjacent amino acid residues, P2 and P3, both buried in the peptide binding groove of H-2Kb, determine mouse Ly49C specificity. If both are aliphatic residues, this is supportive. Whereas, small amino acids at P2 and aromatic amino acids at the P3 auxiliary anchor residue are detrimental to Ly49C recognition. These results resemble those with a rat Ly49 where the identity of a peptide anchor residue determines recognition, suggesting that dependence on specific peptide residues buried in the MHC-I peptide-binding groove may be fundamental to Ly49 peptide selectivity and recognition.

Indexed as

AllelesAmino AcidsAnimalsBinding SitesCell Line, TumorH-2 AntigensHistocompatibility Antigens Class IMiceModels, MolecularNK Cell Lectin-Like Receptor Subfamily AOligopeptidesPeptidesProtein BindingProtein ConformationRatsReceptors, NK Cell Lectin-LikeAmino AcidsH-2 AntigensHistocompatibility Antigens Class IMHC binding peptideNK Cell Lectin-Like Receptor Subfamily AOligopeptidesPeptidesReceptors, NK Cell Lectin-Like

Identifiers

PMID26147851
PMCPMC4493100
OpenAlexW809286279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.